MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.

Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.

Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.

Home Federal Bancorp, Inc. of Louisiana is a holding company, which provides financial services to individuals, corporate entities, and other organizations. It provides services through the origination of loans and the acceptance of deposits in the form of passbook savings, certificates of deposit, and demand deposit accounts. The company was founded on April 1, 1924 and is headquartered in Shreveport, LA.

Issuer Direct Corp. engages in the provision of communications and compliance technology solutions. The company offers Platform id., which eliminates the complexity associated with producing and distributing business communications and financial information. It services focuses on the communications, compliance, annual meeting and proxy, and transfer agency. The company was founded by Brian R. Balbirnie in October 1988 and is headquartered in Raleigh, NC.

Brooge Energy Ltd. operates as an independent oil refinery and storage company. It offers midstream oil storage and services through its subsidiary. The company was founded on April 12, 2019 and is headquartered in Fujairah, United Arab Emirates.

Claros Mortgage Trust, Inc. is a commercial real estate finance company that focuses on originating senior and subordinate loans on transitional CRE assets located in U.S. markets. The transitional CRE assets are properties that require repositioning, renovation, rehabilitation, leasing, development or redevelopment or other value-added elements in order to maximize value. Its objective is to provide debt capital for transitional CRE assets and, in doing so, to generate risk-adjusted returns for its stockholders over time, primarily through dividends. The company was founded on April 29, 2015 and is headquartered in New York, NY.

Advent Technologies Holdings, Inc. operates as an advanced materials and technology development company. It develops, manufactures and assembles hydrogen fuel cell components. The company was founded on June 18, 2018 and is headquartered in Boston, MA.

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Sioux Falls, SD.